Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
This list of potential positions covers USA Equities from Medical Equipment industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty
The Cooper Companies (COO)
The company has Return on Asset of 0.0269 % which means that on every $100 spent on assets, it made $0.0269 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0387 %, implying that it generated $0.0387 on every 100 dollars invested. Cooper Companies' management efficiency ratios could be used to measure how well Cooper Companies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.06. Also, Return On Capital Employed is likely to grow to 0.05. At this time, Cooper Companies' Other Assets are very stable compared to the past year. As of the 23rd of April 2024, Net Tangible Assets is likely to grow to about 2.7 B, while Intangibles To Total Assets are likely to drop 0.32. The firm currently falls under 'Large-Cap' category with a total capitalization of 17.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cooper Companies's market, we take the total number of its shares issued and multiply it by Cooper Companies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Cooper Companies shows a prevailing Real Value of $168.36 per share. The current price of the firm is $91.68. Our model approximates the value of Cooper Companies from analyzing the firm fundamentals such as Profit Margin of 0.08 %, return on equity of 0.0387, and Operating Margin of 0.16 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
iRhythm Technologies (IRTC)
The company has return on total asset (ROA) of (0.1393) % which means that it has lost $0.1393 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5486) %, meaning that it created substantial loss on money invested by shareholders. IRhythm Technologies' management efficiency ratios could be used to measure how well IRhythm Technologies manages its routine affairs as well as how well it operates its assets and liabilities. As of April 23, 2024, Return On Tangible Assets is expected to decline to -0.3. In addition to that, Return On Capital Employed is expected to decline to -0.37. At present, IRhythm Technologies' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 47.3 M, whereas Total Assets are forecasted to decline to about 287.1 M. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 3.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IRhythm Technologies's market, we take the total number of its shares issued and multiply it by IRhythm Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
84.43 Million
At present, IRhythm Technologies' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
Baxter International (BAX)
The company has Return on Asset of 0.0334 % which means that on every $100 spent on assets, it made $0.0334 of profit. This is way below average. Baxter International's management efficiency ratios could be used to measure how well Baxter International manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Baxter International's Return On Tangible Assets are fairly stable compared to the past year. Return On Equity is likely to rise to 0.33 in 2024, whereas Return On Capital Employed is likely to drop 0.02 in 2024. At this time, Baxter International's Non Currrent Assets Other are fairly stable compared to the past year. Intangible Assets is likely to rise to about 6.4 B in 2024, whereas Total Assets are likely to drop slightly above 16.2 B in 2024. This firm currently falls under 'Large-Cap' category with a total capitalization of 20.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Baxter International's market, we take the total number of its shares issued and multiply it by Baxter International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Baxter International shows a prevailing Real Value of $43.9 per share. The current price of the firm is $41.02. Our model approximates the value of Baxter International from analyzing the firm fundamentals such as Profit Margin of 0.18 %, current valuation of 31.75 B, and Return On Equity of -0.0096 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
ICU Medical (ICUI)
The ICU Medical's current Return On Tangible Assets is estimated to increase to -0.01. The current Return On Capital Employed is estimated to decrease to 0.01. As of now, ICU Medical's Total Current Assets are increasing as compared to previous years. The ICU Medical's current Other Current Assets is estimated to increase to about 95.8 M, while Net Tangible Assets are forecasted to increase to (373.7 M). ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ICU Medical's market, we take the total number of its shares issued and multiply it by ICU Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Net Debt
1.52 Billion
As of now, ICU Medical's Net Debt is increasing as compared to previous years.
Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.
Macroaxis Gross Profit
Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty
The Cooper Companies (COO)
The company has Return on Asset of 0.0269 % which means that on every $100 spent on assets, it made $0.0269 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0387 %, implying that it generated $0.0387 on every 100 dollars invested. Cooper Companies' management efficiency ratios could be used to measure how well Cooper Companies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 23rd of April 2024, Return On Tangible Assets is likely to grow to 0.06. Also, Return On Capital Employed is likely to grow to 0.05. At this time, Cooper Companies' Other Assets are very stable compared to the past year. As of the 23rd of April 2024, Net Tangible Assets is likely to grow to about 2.7 B, while Intangibles To Total Assets are likely to drop 0.32. The firm currently falls under 'Large-Cap' category with a total capitalization of 17.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cooper Companies's market, we take the total number of its shares issued and multiply it by Cooper Companies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Cooper Companies shows a prevailing Real Value of $168.36 per share. The current price of the firm is $91.68. Our model approximates the value of Cooper Companies from analyzing the firm fundamentals such as Profit Margin of 0.08 %, return on equity of 0.0387, and Operating Margin of 0.16 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
iRhythm Technologies (IRTC)
The company has return on total asset (ROA) of (0.1393) % which means that it has lost $0.1393 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5486) %, meaning that it created substantial loss on money invested by shareholders. IRhythm Technologies' management efficiency ratios could be used to measure how well IRhythm Technologies manages its routine affairs as well as how well it operates its assets and liabilities. As of April 23, 2024, Return On Tangible Assets is expected to decline to -0.3. In addition to that, Return On Capital Employed is expected to decline to -0.37. At present, IRhythm Technologies' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 47.3 M, whereas Total Assets are forecasted to decline to about 287.1 M. The firm currently falls under 'Mid-Cap' category with a current market capitalization of 3.54 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IRhythm Technologies's market, we take the total number of its shares issued and multiply it by IRhythm Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Short Long Term Debt Total
84.43 Million
At present, IRhythm Technologies' Short and Long Term Debt Total is projected to increase significantly based on the last few years of reporting.
Baxter International (BAX)
The company has Return on Asset of 0.0334 % which means that on every $100 spent on assets, it made $0.0334 of profit. This is way below average. Baxter International's management efficiency ratios could be used to measure how well Baxter International manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Baxter International's Return On Tangible Assets are fairly stable compared to the past year. Return On Equity is likely to rise to 0.33 in 2024, whereas Return On Capital Employed is likely to drop 0.02 in 2024. At this time, Baxter International's Non Currrent Assets Other are fairly stable compared to the past year. Intangible Assets is likely to rise to about 6.4 B in 2024, whereas Total Assets are likely to drop slightly above 16.2 B in 2024. This firm currently falls under 'Large-Cap' category with a total capitalization of 20.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Baxter International's market, we take the total number of its shares issued and multiply it by Baxter International's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Baxter International shows a prevailing Real Value of $43.9 per share. The current price of the firm is $41.02. Our model approximates the value of Baxter International from analyzing the firm fundamentals such as Profit Margin of 0.18 %, current valuation of 31.75 B, and Return On Equity of -0.0096 as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
ICU Medical (ICUI)
The ICU Medical's current Return On Tangible Assets is estimated to increase to -0.01. The current Return On Capital Employed is estimated to decrease to 0.01. As of now, ICU Medical's Total Current Assets are increasing as compared to previous years. The ICU Medical's current Other Current Assets is estimated to increase to about 95.8 M, while Net Tangible Assets are forecasted to increase to (373.7 M). ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ICU Medical's market, we take the total number of its shares issued and multiply it by ICU Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Net Debt
1.52 Billion
As of now, ICU Medical's Net Debt is increasing as compared to previous years.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management. View Profile
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com
Did you try this?
Run Stock Screener Now
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
